#cancer-screening

[ follow ]

Impacts of prevention, screening, treatment on cancer deaths

Prevention and screening advancements have saved more lives from cancer than treatment innovations over the past 45 years.
#nhs

Warning over cancer screenings for trans people in England

Trans people in England are missing vital cancer screenings due to healthcare system failures and misalignment of GP records.
Solutions must involve direct collaboration with trans patients to ensure equitable access to healthcare.

NHS to review prostate cancer testing after Chris Hoy call for change

There is a strong push to lower the age for prostate cancer testing following Sir Chris Hoy's appeal, potentially improving early detection among younger men.

Warning over cancer screenings for trans people in England

Trans people in England are missing vital cancer screenings due to healthcare system failures and misalignment of GP records.
Solutions must involve direct collaboration with trans patients to ensure equitable access to healthcare.

NHS to review prostate cancer testing after Chris Hoy call for change

There is a strong push to lower the age for prostate cancer testing following Sir Chris Hoy's appeal, potentially improving early detection among younger men.
morenhs
#health-care

How AI can help researchers make esophageal cancer less deadly

Esophageal cancer detection is often too late for effective treatment, underlining the need for improved screening methods.

Op-Ed | Why we must pass the Medicare Multi-Cancer Early Detection Screening Coverage Act | amNewYork

Congress has the opportunity to pass the Medicare Multi-Cancer Early Detection Screening Coverage Act to improve cancer screening access for at-risk communities.

How AI can help researchers make esophageal cancer less deadly

Esophageal cancer detection is often too late for effective treatment, underlining the need for improved screening methods.

Op-Ed | Why we must pass the Medicare Multi-Cancer Early Detection Screening Coverage Act | amNewYork

Congress has the opportunity to pass the Medicare Multi-Cancer Early Detection Screening Coverage Act to improve cancer screening access for at-risk communities.
morehealth-care
#prostate-cancer

The Dark Side of Prostate Cancer Screening: An Epidemic of Overdiagnosis & Overtreatment

Prostate cancer overdiagnosis is a significant issue due to the detection of indolent tumors that would not cause harm, leading to unnecessary treatments and side effects.

Thousands take part in prostate cancer trial in bid to revolutionise detection

A revolutionary UK screening trial for prostate cancer aims to discover effective and safe screening methods to detect early stages of the disease.

The Dark Side of Prostate Cancer Screening: An Epidemic of Overdiagnosis & Overtreatment

Prostate cancer overdiagnosis is a significant issue due to the detection of indolent tumors that would not cause harm, leading to unnecessary treatments and side effects.

Thousands take part in prostate cancer trial in bid to revolutionise detection

A revolutionary UK screening trial for prostate cancer aims to discover effective and safe screening methods to detect early stages of the disease.
moreprostate-cancer
#early-detection

Study Puts a $43 Billion Yearly Price Tag on Cancer Screening

The United States spends $43 billion annually on cancer screening, a substantial portion of the $250 billion spent on cancer overall.

Experts Shared 5 Signs That You Should Get A Colonoscopy Before Age 45

Colorectal cancer rates increasing in younger adults in the US.
Importance of early screening for colorectal cancer based on symptoms.

Study Puts a $43 Billion Yearly Price Tag on Cancer Screening

The United States spends $43 billion annually on cancer screening, a substantial portion of the $250 billion spent on cancer overall.

Experts Shared 5 Signs That You Should Get A Colonoscopy Before Age 45

Colorectal cancer rates increasing in younger adults in the US.
Importance of early screening for colorectal cancer based on symptoms.
moreearly-detection

Incidence of 17 cancers on the rise in younger generations, major new study says

Gen X and Millennials in the U.S. show increased risk for 17 cancers compared to previous generations, with some cancers spiking among younger age groups.
#fda-approval

F.D.A. Approves Blood Test for Colon Cancer Detection

The FDA approved a new blood test for colorectal cancer, simpler than other screening methods, aiming to increase early-stage cancer detection and reduce cancer-related deaths.

FDA approves blood test for colorectal cancer

Blood test approved by FDA for colorectal cancer detection in individuals aged 45 and older, offering an additional screening option.
Detection limitations: The Shield test may not detect early-stage colorectal cancer and misses 87% of precancerous growths, not replacing a colonoscopy.
State of play: Shield test by Guardant to launch soon with FDA approval, becoming the first blood test for colorectal cancer for average-risk individuals eligible for Medicare coverage.

A simple blood test can detect colorectal cancer early, study finds

Blood test can detect 83% of colorectal cancer cases
FDA approval could offer a less invasive screening option

F.D.A. Approves Blood Test for Colon Cancer Detection

The FDA approved a new blood test for colorectal cancer, simpler than other screening methods, aiming to increase early-stage cancer detection and reduce cancer-related deaths.

FDA approves blood test for colorectal cancer

Blood test approved by FDA for colorectal cancer detection in individuals aged 45 and older, offering an additional screening option.
Detection limitations: The Shield test may not detect early-stage colorectal cancer and misses 87% of precancerous growths, not replacing a colonoscopy.
State of play: Shield test by Guardant to launch soon with FDA approval, becoming the first blood test for colorectal cancer for average-risk individuals eligible for Medicare coverage.

A simple blood test can detect colorectal cancer early, study finds

Blood test can detect 83% of colorectal cancer cases
FDA approval could offer a less invasive screening option
morefda-approval

Canadian doctors are using 'outdated' guidelines to screen for cancer, experts warn | CBC News

Breast cancer diagnosis delayed due to lack of routine screening under age 50 in Canada.

NCI Launches Cancer Screening Research Network

The NIH launched the Cancer Screening Research Network (CSRN) to evaluate emerging technologies for cancer screening.
The network will focus on identifying cancers earlier to enhance treatment outcomes and extend lives.
[ Load more ]